Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy Subject
Clinical trial NCT01161355 · COMPLETED
Trial details
- NCT number
- NCT01161355
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2010-06-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.